Abstract
Asthma has been defined as “[a] disease characterized by an increased responsiveness of the airways to various stimuli and manifested by slowing of forced expiration which changes in severity either spontaneously or as a result of therapy” (Joint Committee on Pulmonary Nomenclature, 1975). According to Wilson (1983a), asthma occurs in between 2 and 20% of the population in developed countries. It is a major health problem because of its disabling and disruptive nature, which often demands changes in lifestyle, and because it is associated with prolonged morbidity and some mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramowicz, M., ed.: Beclomethasone dipropionate (Vanceril) for asthma. Med. Lett. 18:76, 1976.
Abramowicz, M., ed.: Corticosteroid aerosols for asthma. Med. Lett. 27:5, 6,1985.
Abramowicz, M., ed.: Drugs for asthma. Med. Lett. 29:11–16, 1987.
Berkow R., ed.: The Merck Manual, 14th Ed., Merck Sharp & Dohme Research Laboratories, Rahway, NJ, 1982.
Brattsand, R., Thalén, A., Roempke, K., Källström, L., and Gruvstad, E.: Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. Eur. J. Respir. Dis. 63 (Suppl. 122): 62–73, 1982.
Brockbank, W. and Pengelly, C. D. R.: Chronic asthma treated with powder inhalations of hydrocortisone and prednisolone. Lancet 1:187,188, 1958.
Brockbank, W., Brebner, H., and Pengelly, C. D. R.: Chronic asthma treated with aerosol hydrocortisone. Lancet 2:807, 1956.
Brogden, R.N.: Inhaled steroids: Studies in adult and childhood asthma, in Steroids in Asthma: A Reappraisal in the Light of Inhalation Therapy, T. J. H. Clark, ed., pp. 135–153, Adis, Auckland, 1983.
Brogden, R. N., Heel, R. C., Speight, T. M., and Avery, G. S.: Beclometha-sone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 28:99–126, 1984.
Brogden, R. N., Pinder, R. M., Sawyer, P. R., Speight, T. M., and Avery, G. S.: Beclomethasone dipropionate inhaler: A review of its pharmacology, therapeutic value and adverse effects. I: Asthma. Drugs 10: 166–210, 1975.
Brown, H. M.: The Introduction and early development of inhaled steroid treatment, in Topical Steroid Treatment for Asthma and Rhinitis, N. Mygind and T. J. H. Clark, eds., pp. 66–76, Ballière Tindall, London, 1980.
Brown, H. M., Storey, G., and George, W. H. S.: Beclomethasone dipropionate: A new steroid aerosol for the treatment of allergic asthma. Br. Med. J. 1:585–590, 1972.
Caldwell, I. W., Hall-Smith, S. P., Main, R. A., Ashurst, P. J., Kirton, V., Simpson, W. T., and Williams, G. W.: Clinical evaluation of a new topical corticosteroid beclomethasone dipropionate. Br. J. Dermatol. 80: 111–117, 1968.
Carryer, H. M., Koelsche, G. A., Prickman, L. E., Maytum, C. K., Lake, C. F., and Williams, H. L.: The effect of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. J. Allergy 21:282–287, 1950.
Choo-Kang, Y. F. J., Cooper, E. J., Tribe, A. E., and Grant, I. W. B.: Beclomethasone dipropionate by inhalation in the treatment of airways obstruction. Br. J. Dis. Chest 66:101–106, 1972.
Clark, T. J. H.: Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet 1:1361–1364, 1972.
Clark, T. J. H., ed.: Steroids in Asthma. A Reappraisal in the Light of Inhalation Therapy, Adis, Auckland, 1983.
Clark, T. J. H. and McAllister, W. A. C: Corticosteroids, in Asthma, 2nd Ed., T. J. H. Clark and S. Godfrey, eds., pp. 372–392, Chapman and Hall, London, 1983.
Cochrane, G. M.: Systemic steroids in asthma, in Steroids in Asthma. A Reappraisal in the Light of Inhalation Therapy, T. J. H. Clark, ed., pp. 103–120, Adis, Auckland, 1983.
Gaddie, J., Petrie, G. R., Reid, I. W., Sinclair, D. J. M., Skinner, C., and Palmer, K. N. V.: Aerosol beclomethasone dipropionate in chronic bronchial asthma. Lancet 1:691–693, 1973.
Gelfand, M. L.: Administration of cortisone by the aerosol method in the treatment of bronchial asthma. N. Engl. J. Med. 245:293,294,1951.
Glaxo Group Ltd.: 17α,21-Diacyloxy-9α-halo-llβ-hydroxy-16β-methyl-pregna-l,4-diene-3,20-diones. (Belgium Patent 649,170. Dec. 11,1964) Chem. Abst. 64:15958c, 1966.
Gregg, I.: Treatment of asthma with beclomethasone aerosol. Br. Med. J. 2:110, 1972.
Harris, D. M., Martin, L. E., Harrison, C., and Jack, D.: The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin. Allergy 3:243–248, 1973.
Helm, W. H. and Hey worth, F.: Bronchial asthma and chronic bronchitis treated with hydrocortisone acetate inhalations. Br. Med. J. 2:765–768, 1958.
Hench, P. S., Kendall, E. C., Slocumb, C. H., and Polley, H. F.: The effect of the hormone of the adrenal cortex (17-hydroxy-ll-dehydrocorti-costerone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc. Staff Mtg. Mayo Clinic 24:181–197, 1949.
Herxheimer, H.: Beclomethasone aerosol in asthma. Lancet 2:91,92,1972.
Hoffbrand, B. I. and Harris, D. M., eds.: Beclomethasone dipropionate aerosols. Postgrad. Med. J. 51 (Suppl. 4): 1–113, 1975.
Joint Committee on Pulmonary Nomenclature: Pulmonary terms and symbols. Chest 67:583–593, 1975.
Lai, S., Harris, D. M., Bhalla, K. K., Singhal, S. N., and Butler, A. G.: Comparison of beclomethasone dipropionate aerosol and prednisolone in reversible airways obstruction. Br. Med. J. 3:314–317, 1972.
Lampe, K. F., ed.: Drug Evaluations, 6th Ed., American Medical Association, Chicago, 1986.
Langlands, J. H. M. and McNeill, R. S.: Hydrocortisone by inhalation: Effects on lung function in bronchial asthma. Lancet 2:404–406, 1960.
Linder, W. R.: Adrenal suppression by aerosol steroid inhalation. Arch. Intern. Med. 113:655,656,1964.
McKenzie, A. W.: Percutaneous absorption of steroids. Arch. Dermatol. 86:611–614, 1962.
Martin, L. E., Harrison, C., and Tanner, R. J. N.: Metabolism of beclomethasone dipropionate by animals and man. Postgrad. Med. J. 51 (Suppl. 4): 11–20, 1975.
Martin, L. E., Tanner, R. J. N., Clark, T. J. H., and Cochrane, G. M.: Absorption and metabolism of orally administered beclomethasone dipro-pionate. Clin. Pharmacol. Ther. 15:267–275, 1974.
Meltzer, E. O., Kemp, J. P., Welch, M. J., and Orgel, H.A.: Effect of dosing schedule on efficacy of beclomethasone dipropionate aerosol in chronic asthma. Am. Rev. Respir. Dis. 131:732–736, 1985.
Mygind, N. and Clark, T. J. H., eds.: Topical Steroid Treatment for Asthma and Rhinitis. Balliere Tindall, London, 1980.
Novey, H. S. and Beall, G.: Aerosolized steroids and induced Cushing’s syndrome. Arch. Intern. Med. 115:602–605, 1965.
Phillips, G. H.: Locally active corticosteroids: Structure activity relationships, in Mechanisms of Topical Corticosteroid Activity. L. C. Wilson and R. Marks, eds., pp. 1–18, Churchill Livingstone, Edinburgh, 1976.
Raffle, E. J. and Frain-Bell, W.: The effect of topically applied beclomethasone dipropionate on adrenal function. Br. J. Dermatol. 79: 487–490, 1967.
Raffle, E. J. and Frain-Bell, W.: The effect of topically applied beclomethasone. Br. J. Dermatol. 80:124, 1968.
Siegel, S. G: Corticosteroid agents: Overview of corticosteroid therapy. J. Allergy Clin. Immunol. 76:312–320, 1985.
Siegel, S. C., Heimlich, E. M., Richards, W., and Kelley, V. G: Adrenal function in allergy. IV. Effect of dexamethasone aerosols in asthmatic children. Pediatrics 33:245–250, 1964.
Smith, J. M.: Hydrocortisone hemisuccinate by inhalation in children with asthma. Lancet 2:1248,1249,1958.
Toogood, J. H. and Lefcoe, N. M.: Dexamethasone aerosol for the treatment of “steroid dependent” chronic bronchial asthmatic patients. J. Allergy 36:321–332, 1965.
Tse, C. S. T. and Bernstein, I. L.: Corticosteroid aerosols in the treatment of asthma. Pharmacotherapy 4:334–342, 1984.
Wilson, J. D.: Asthma: The dimension of the problem, in Steroids in Asthma: A Reappraisal in the Light of Inhalation Therapy, T. J. H. Clark, ed., pp. 1–10, Adis, Auckland, 1983a.
Wilson, J. D.: Asthma and Allergic Diseases: A Clinician’s Guide to Diagnosis and Management, Adis Health Sci., Sydney, 1983b.
Wilson, L. and Marks, R., eds.: Mechanisms of Topical Corticosteroid Activity, Churchill Livingstone, Edinburgh, 1976.
Williams, M.H., Jr.: Beclomethasone dipropionate. Ann. Intern. Med. 95: 464–167, 1981.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maxwell, R.A., Eckhardt, S.B. (1990). Beclomethasone Dipropionate. In: Drug Discovery. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0469-5_26
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0469-5_26
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6775-1
Online ISBN: 978-1-4612-0469-5
eBook Packages: Springer Book Archive